Cannell Peter B & Company Decreased By $458,592 Its Abbvie (ABBV) Stake; Smead Capital Management Lowered Starbucks (SBUX) Stake

April 19, 2018 - By Adrian Erickson

Starbucks Corporation (NASDAQ:SBUX) Logo

Cannell Peter B & Company Inc decreased Abbvie Inc (ABBV) stake by 0.92% reported in 2017Q4 SEC filing. Cannell Peter B & Company Inc sold 4,777 shares as Abbvie Inc (ABBV)’s stock declined 6.31%. The Cannell Peter B & Company Inc holds 515,580 shares with $49.86M value, down from 520,357 last quarter. Abbvie Inc now has $146.36B valuation. The stock decreased 2.21% or $2.08 during the last trading session, reaching $92.24. About 1.02 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since April 19, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Smead Capital Management Inc decreased Starbucks Corp (SBUX) stake by 4.48% reported in 2017Q4 SEC filing. Smead Capital Management Inc sold 16,529 shares as Starbucks Corp (SBUX)’s stock rose 0.28%. The Smead Capital Management Inc holds 352,196 shares with $20.23 million value, down from 368,725 last quarter. Starbucks Corp now has $83.28B valuation. The stock decreased 0.42% or $0.25 during the last trading session, reaching $59.25. About 1.73M shares traded. Starbucks Corporation (NASDAQ:SBUX) has risen 0.40% since April 19, 2017 and is uptrending. It has underperformed by 11.15% the S&P500.

Analysts await Starbucks Corporation (NASDAQ:SBUX) to report earnings on April, 26 after the close. They expect $0.53 earnings per share, up 17.78% or $0.08 from last year’s $0.45 per share. SBUX’s profit will be $744.97M for 27.95 P/E if the $0.53 EPS becomes a reality. After $0.65 actual earnings per share reported by Starbucks Corporation for the previous quarter, Wall Street now forecasts -18.46% negative EPS growth.

Since January 31, 2018, it had 0 buys, and 3 sales for $13.62 million activity. 59,838 shares valued at $3.60M were sold by WEATHERUP CRAIG on Tuesday, March 13. $740,851 worth of stock was sold by ULLMAN MYRON E III on Monday, March 12. BURROWS CLIFFORD had sold 162,826 shares worth $9.28M on Wednesday, January 31.

Investors sentiment increased to 1.05 in Q4 2017. Its up 0.08, from 0.97 in 2017Q3. It increased, as 63 investors sold SBUX shares while 449 reduced holdings. 114 funds opened positions while 423 raised stakes. 983.38 million shares or 1.10% more from 972.68 million shares in 2017Q3 were reported. 53,160 were reported by Hoertkorn Richard Charles. Manchester Cap Mgmt Limited Liability Co holds 5,471 shares or 0.05% of its portfolio. Vista Capital Prtn Inc reported 0.25% stake. The Switzerland-based Credit Suisse Ag has invested 0.13% in Starbucks Corporation (NASDAQ:SBUX). Marshall And Sullivan Wa stated it has 15,434 shares or 0.71% of all its holdings. Ancora Advsrs Limited Liability has invested 0.03% in Starbucks Corporation (NASDAQ:SBUX). First holds 0.04% or 7,096 shares. Stifel Fincl has invested 0.26% in Starbucks Corporation (NASDAQ:SBUX). Honeywell Intll Inc accumulated 709,462 shares. Nbt Financial Bank N A New York holds 0.03% in Starbucks Corporation (NASDAQ:SBUX) or 3,494 shares. Lowe Brockenbrough & Inc reported 36,345 shares stake. Tnb Fincl invested in 4,066 shares or 0.04% of the stock. Chevy Chase reported 0.36% in Starbucks Corporation (NASDAQ:SBUX). Keybank National Association Oh stated it has 0.34% of its portfolio in Starbucks Corporation (NASDAQ:SBUX). Oregon Pub Employees Retirement Fund owns 0.37% invested in Starbucks Corporation (NASDAQ:SBUX) for 423,755 shares.

Among 37 analysts covering Starbucks Corporation (NASDAQ:SBUX), 23 have Buy rating, 0 Sell and 14 Hold. Therefore 62% are positive. Starbucks Corporation had 105 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, March 9 by UBS. The firm earned “Buy” rating on Friday, January 26 by Piper Jaffray. The rating was maintained by UBS with “Buy” on Thursday, March 15. BMO Capital Markets maintained the stock with “Hold” rating in Tuesday, October 3 report. The firm has “Buy” rating by RBC Capital Markets given on Tuesday, June 13. The firm has “Hold” rating given on Thursday, September 3 by Zacks. The rating was downgraded by Vetr to “Strong-Buy” on Friday, August 28. The rating was maintained by Deutsche Bank on Wednesday, November 2 with “Hold”. The stock of Starbucks Corporation (NASDAQ:SBUX) earned “Hold” rating by Stifel Nicolaus on Friday, March 18. Credit Suisse maintained it with “Neutral” rating and $54 target in Friday, November 3 report.

Since October 30, 2017, it had 0 insider purchases, and 12 selling transactions for $49.35 million activity. The insider Michael Robert A. sold 992 shares worth $119,351. $311,684 worth of AbbVie Inc. (NYSE:ABBV) shares were sold by SEVERINO MICHAEL. Shares for $2.15M were sold by RICHMOND TIMOTHY J. on Wednesday, February 28. On Wednesday, February 28 the insider CHASE WILLIAM J sold $8.31M. GONZALEZ RICHARD A sold $976,084 worth of stock. $157,458 worth of AbbVie Inc. (NYSE:ABBV) shares were sold by SALEKI-GERHARDT AZITA. Another trade for 25,000 shares valued at $2.95 million was sold by Schumacher Laura J.

Cannell Peter B & Company Inc increased Chubb Ltd stake by 8,706 shares to 253,462 valued at $37.04 million in 2017Q4. It also upped Royal Dutch Shell Plc stake by 570,560 shares and now owns 909,823 shares. Accelerate Diagnostics Inc (NASDAQ:AXDX) was raised too.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc had 89 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, April 19 by BMO Capital Markets. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Jefferies on Friday, April 13. As per Friday, October 23, the company rating was maintained by UBS. As per Friday, March 10, the company rating was maintained by Goldman Sachs. The stock has “Neutral” rating by Citigroup on Monday, November 28. Deutsche Bank initiated it with “Hold” rating and $63 target in Tuesday, March 15 report. The stock of AbbVie Inc. (NYSE:ABBV) has “Neutral” rating given on Thursday, September 8 by JP Morgan. Raymond James initiated it with “Outperform” rating and $82 target in Friday, September 2 report. On Monday, June 26 the stock rating was maintained by Jefferies with “Buy”. The stock of AbbVie Inc. (NYSE:ABBV) has “Buy” rating given on Sunday, October 29 by SunTrust.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.05, from 0.85 in 2017Q3. It dived, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Adage Prns Group Llc has invested 0.47% in AbbVie Inc. (NYSE:ABBV). Jnba Fincl holds 0.21% in AbbVie Inc. (NYSE:ABBV) or 10,275 shares. Eagle Global Advisors Llc reported 0.03% of its portfolio in AbbVie Inc. (NYSE:ABBV). Yorktown Mgmt Com reported 19,200 shares stake. Guinness Asset Management reported 135,100 shares. 30,566 were accumulated by Zeke Advsr Limited Liability. Haverford has invested 0.17% in AbbVie Inc. (NYSE:ABBV). Monetary Mngmt Grp stated it has 1.66% of its portfolio in AbbVie Inc. (NYSE:ABBV). Taylor Frigon Management Lc invested in 1.1% or 14,040 shares. Carroll Finance Assoc has invested 0.06% in AbbVie Inc. (NYSE:ABBV). Intrust Bank & Trust Na holds 0.44% or 15,401 shares in its portfolio. The Virginia-based Signature Finance Mgmt has invested 0.11% in AbbVie Inc. (NYSE:ABBV). Utah Retirement System holds 296,505 shares or 0.6% of its portfolio. Verus Fincl Prns has 0.09% invested in AbbVie Inc. (NYSE:ABBV). Employees Retirement System Of Texas holds 0.41% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 332,100 shares.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on April, 26 before the open. They expect $1.78 EPS, up 39.06% or $0.50 from last year’s $1.28 per share. ABBV’s profit will be $2.82 billion for 12.96 P/E if the $1.78 EPS becomes a reality. After $1.48 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth.

Starbucks Corporation (NASDAQ:SBUX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>